BALCHEM CORP (BCPC) Stock
4 members of Congress disclosed 7 trades in BCPC since 2015: 3 purchases and 4 sales, most recently Gilbert Cisneros (purchase, Sep 17, 2026). 7 of the hedge funds AlphaScala tracks reported BCPC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $32.66M.
Which members of Congress traded BALCHEM CORP (BCPC)?
Most recent: Gilbert Cisneros (purchase, Sep 17, 2026); records start Feb 13, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-09-17 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-07-10 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2025-04-09 | partial sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2021-12-02 | partial sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2020-05-21 | purchase | $1k – $15k |
| Donna Shalala D-FL · House | 2019-06-24 | sale | $1k – $15k |
| Thom Tillis R-NC · Senate | 2015-02-13 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all BCPC political trades →Which hedge funds own BCPC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Renaissance Technologies Jim Simons (founder) | 193K | $32.66M | +9% |
| Millennium Management Israel Englander | 185K | $31.18M | +57% |
| Marshall Wace | 98K | $16.53M | +138% |
| Citadel Ken Griffin | 62K | $10.41M | +198% |
| Point72 Steve Cohen | 26K | $4.36M | -72% |
| Bridgewater Associates Ray Dalio | 13K | $2.27M | -23% |
| D.E. Shaw David Shaw | 9K | $1.50M | -78% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →BCPC price chart
Powered by TradingViewWhat does BALCHEM CORP do?
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for diverse industries worldwide. Operating through three key segments, it leads in Human Nutrition and Health, providing human-grade choline nutrients, mineral amino acid chelated products, and ingredients for food, beverage, pharmaceutical, and health applications. The Animal Nutrition and Health segment delivers nutritional solutions derived from microencapsulation and chelation technologies, including essential nutrient choline chloride for animal feed. The Specialty Products segment focuses on repackaging and distributing performance gases and chemicals for medical device sterilization, plant nutrition, and industrial uses. Balchem Corporation serves nutritional, food, pharmaceutical, animal health, and industrial markets, emphasizing innovative solutions that enhance health and performance. Founded in 1967 and headquartered in New Jersey, it plays a vital role in the specialty chemicals sector by supplying high-quality, technology-driven ingredients to support global health, nutrition, and industrial needs.